+43-123-13-985|info@ces.b2sg.org
News 2017-05-19T11:28:28+00:00

Stephan Beck, Editor of Cancer Epigenetics

The Cancer Epigenetics Society is happy to announce the appointment of Dr. Stephan Beck to the Editorial Board of Cancer Epigenetics. Dr. Stephan Beck is Professor of Medical Genomics at University College London Cancer Institute (London, UK), and is one of the pioneers and a leader of the field [...]

September 6th, 2017|Categories: News|Tags: , , , |

Ayalew Tefferi, Editor of Clinical Cancer Epigenetics

The Cancer Epigenetics Society is happy to announce the appointment of Dr. Ayalew Tefferi to the Editorial Board of Clinical Cancer Epigenetics. Dr. Tefferi is Professor of Hematology and of Internal Medicine at the Mayo Clinic (Rochester, MN, USA). He also serves as a Board Review Course Faculty at [...]

September 3rd, 2017|Categories: News|Tags: , , , |

Owen O’Connor, Editor of Clinical Cancer Epigenetics

The Cancer Epigenetics Society is happy to announce the appointment of Dr. Owen A. O'Connor to the Editorial Board of Clinical Cancer Epigenetics. Dr. O’Connor is Professor of Medicine and Experimental Therapeutics at Columbia University and Director of the Center for Lymphoid Malignancies at the Herbert Irving Comprehensive Cancer [...]

July 20th, 2017|Categories: News|Tags: , , |

Stephen Baylin elected to the National Academy of Sciences, USA

We are proud to announce that Prof. Stephen B. Baylin, Officer at the Cancer Epigenetics Society and Editor of Cancer Epigenetics, was elected to the National Academy of Sciences, USA. This distinction is in recognition of his work in basic and applied research in the fields of epigenetics and [...]

The Cancer Epigenetics Society gains in popularity

The Cancer Epigenetics Society, launched only last year, continues to be ever more popular, with more people from more countries using its resources. In the social media such as LinkedIn, the Cancer Epigenetics Society has a larger size audience as that of EpiCypher (founded in 2012), EpiGentek (founded in [...]

July 16th, 2017|Categories: News|Tags: , , |

Appointment of Cigall Kadoch, Editor of Cancer Epigenetics

The Cancer Epigenetics Society is very happy to announce the appointment of Dr. Cigall Kadoch to the Editorial Board of the Cancer Epigenetics journals series. Dr. Kadoch is an expert of ATP-dependent mammalian SWI/SNF chromatin remodeling machineries, with a particular interest in locus-specific and genome-wide modulation by BAF complexes in [...]

July 12th, 2017|Categories: News|Tags: , , , , |

Appointment of Lucy Godley, Editor of Cancer Epigenetics

The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Lucy Godley to the Editorial Board of the Cancer Epigenetics journals series. Dr. Godley is an expert of myeloid malignancies with a particular interest in DNA methylation and hydroxymethylation role in normal and neoplastic hematopoiesis. She also [...]

July 10th, 2017|Categories: News|Tags: , , |

The Cancer Epigenetics Society is a COST-Epichembio Member

The Cancer Epigenetics Society is as of July 1, 2017 a Full Member of Epichembio, an EU-funded initiative of the European Cooperation in Science and Technology (COST). Epichembio (Epigenetic Chemical Biology) regroups scientists and research institutions from 34 countries, making it one of the largest international networks in epigenetics [...]

The Cancer Epigenetics Society on YouTube

The Cancer Epigenetics Society is now on YouTube with short videos relevant to cancer and/or epigenetics. The Society's first video follows the timeline of DNA-based epigenetics with several findings relevant to cancer biology or treatment. The second video highlights cancer rates in the top 50 most affected countries, showing [...]

June 23rd, 2017|Categories: News|Tags: , , , |

The Cancer Epigenetics Society is a UICC Member

The Cancer Epigenetics Society is as of June 15, 2017, a Full Member of the Union for International Cancer Control (UICC)! UICC is an NGO located in Geneva, Switzerland, that brings together an exclusive worldwide coalition of the major players in cancer control. It works closely with the International [...]

June 20th, 2017|Categories: News|Tags: , |

Raul Urrutia, Chief Science Officer of the Cancer Epigenetics Society

The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Raul A. Urrutia as the Society's Chief Science Officer. Dr. Urrutia joins the leadership of the Cancer Epigenetics Society from the Mayo Clinic at Rochester where he holds full Professorships in Medicine, Biochemistry and Molecular Biology, [...]

May 16th, 2017|Categories: News|Tags: , , |

Appointment of Cheryl Arrowsmith, Editor of Cancer Epigenetics

The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Cheryl H. Arrowsmith to the Editorial Board of Cancer Epigenetics journals series. Dr. Arrowsmith holds the Canada Chair in Structural Genomics and is Chief Scientist of the Structural Genomics Consortium (SGC) Toronto laboratories. Dr. Arrowsmith is also Professor [...]

May 3rd, 2017|Categories: News|Tags: , , , |

The Cancer Epigenetics Society is 1 year old!

The Cancer Epigenetics Society was on top of the world as it celebrated its 1st anniversary at the Loft restaurant and bar on the top floor of the Sofitel hotel in Vienna, Austria. The Cancer Epigenetics Society has achieved extraordinary progress in its relatively short existence so far, producing several [...]

April 28th, 2017|Categories: News|Tags: , , |

The third annual Epigenetics Discovery Congress

The Cancer Epigenetics Society is happy to announce its partnership with the 3rd Annual Epigenetics Discovery Congress that takes place in London, from the 12th to the 13th of October 2017. The meeting will cover several aspects of epigenetics and cancer epigenetics, including transgenerational epigenetics, novel epigenetic targets, epigenetics in [...]

March 21st, 2017|Categories: News|Tags: , |

Appointment of Peter-Jones, Editor-in-Chief at CE

The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Peter Jones, Chief Scientific Officer of Van Andel Research Institute (VARI, Grand Rapids, MI, USA), as co-Editor-in-Chief of the Cancer Epigenetics journal series. Dr. Jones is a world renown DNA methylation expert who was first to show [...]

March 13th, 2017|Categories: News|Tags: , , , |

Appointment of Jerry Workman, Editor at CE

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Jerry Workman to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Workman is an Investigator at the Stowers Institute for Medical Research (Kansas City, MO, USA). Prior to his current position, Dr. Workman was [...]

March 8th, 2017|Categories: News|Tags: , , |

Dr. Sabine Oberhauser (30 August 1963 – 23 February 2017), here with Austria’s President Heinz Fischer

It is with great sadness that we learned of the passing of Dr. Sabine Oberhauser, Health Minister of Austria since 9/2014. Dr. Oberhauser suffered from cancer since early 2015. Not least among her many accomplishments is her commitment to fight cancer by forbiding smoking in restaurants nationwide, which should take [...]

February 24th, 2017|Categories: News|Tags: |

Appointment of Sharon Dent, Editor-in-Chief at CE

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Sharon Y. R. Dent to the position of co-Editor-in-Chief of the Cancer Epigenetics (CE) journal series. Dr. Dent is Professor and holds the J. Ralph Meadows Chair of the Department of Epigenetics and Molecular Carcinogenesis at University [...]

February 21st, 2017|Categories: News|Tags: , , , |

Appointment of Tatiana Kutateladze, Editor at CE

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Tatiana Kutateladze to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Kutateladze is a Professor of Pharmacology at the University of Colorado School of Medicine (Aurora, CO, USA). Her research interests include studying epigenetic [...]

January 9th, 2017|Categories: News|Tags: , , |

Cancer Epigenetics Society announces partnership with Treat Mesothelioma

The Cancer Epigenetics Society enters into a partnership with Treat Mesothelioma to better support mesothelioma patients worldwide. Treat Mesothelioma is dedicated to the assistance and guidance of asbestos and mesothelioma victims around the world. Treat Mesothelioma is also meant to inspire hope and to provide information and resources to help [...]

January 8th, 2017|Categories: News|Tags: |

Appointment of Luciano Di Croce, Editor at CE

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Luciano Di Croce to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Di Croce is the Leader of Epigenetics Events in Cancer Group at the Centre for Genomic Regulation (CGR), an international biomedical research [...]

December 21st, 2016|Categories: News|Tags: , , , |

Appointment of Giacomo Cavalli, Editor at CE

The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Giacomo Cavalli to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Cavalli is is Head of the Chromatin and Cell Biology Laboratory at the Institute for Human Genetics (Montpellier, France). He is also a [...]

December 8th, 2016|Categories: News|Tags: , , |

Appointment of Jonathan D. Licht, MD, Editor at CE

The Cancer Epigenetics Society officially appoints Dr. Jonathan D. Licht, Editor at Cancer Epigenetics (CE) journal series. Dr. Licht is Director of University of Florida Health Cancer Center (Gainesville, FL, USA), and holds the Marshall E. Rinker Sr. Foundation and David B and Leighan R. Rinker Chair. Before that, Dr. Licht [...]

November 28th, 2016|Categories: News|Tags: , , |

Appointment of Keith D. Robertson Vice-President of the Cancer Epigenetics Society

The Cancer Epigenetics Society officially appoints Dr. Keith Robertson, Officer at the Cancer Epigenetics Society and Professor of Molecular Pharmacology & Experimental Therapeutics at Mayo Clinic, Rochester (MN, USA), Vice-President of the Cancer Epigenetics Society. Keith earned his Bachelor’s degree from Cornell University, and his PhD from Johns Hopkins University. He [...]

November 24th, 2016|Categories: News|Tags: , , , |

Arid1a: a fertile target in the parched anticancer drug landscape

Recent work from several labs have shown ARID1A, the helicase/ATPase-containing SWI/SNF chromatin-remodeling factor, to be mutated in several cancers, most notably in ovarian cancer (some 50% of ovarian clear-cell carcinoma). Other cancers in which ARID1A was reported to be mutated include Sézary syndrome (a leukemic form of cutaneous T cell lymphoma; [...]

November 17th, 2016|Categories: News|Tags: , , |

Cancer Epigenetics Society announces first partnership with Mexico

The Cancer Epigenetics Society enters into a partnership with the Mexican Society of Epigenetics and Regenerative Medicine, thus marking the beginning of a program of collaborations between the Cancer Epigenetics Society and research institutions and societies in Mexico and other Latin American countries. The two societies will be working closely [...]

November 15th, 2016|Categories: News|Tags: |

Cancer Epigenetics Database, Experimental section: KDMi are in!

The experimental section of the Cancer Epigenetics Drug Database has been expanded to now include a fourth class of epigenetics-targeting drugs: the inhibitors of histone (lysine) demethylases or KDMi. This database currently includes data on 9 KDMi and 61 cancer cell lines. Together, the experimental section of the Cancer Epigenetics [...]

Appointment of Susan J. Clark Editor at CE

The Cancer Epigenetics Society officially appoints Dr. Susan J. Clark, Professor at University of New South Wales Faculty of Medicine in Sidney, Australia, Editor at Cancer Epigenetics (CE) journal series. Dr. Clark is also Group Leader of the Laboratory for Epigenetics Research, Head of the Genomics and Epigenetics Division, and Head of [...]

November 2nd, 2016|Categories: News|Tags: , , |

Update on the Cancer Epigenetics Database, Experimental section

We at the Cancer Epigenetics Society have lately focused our efforts on expanding the experimental datasets of the Cancer Epigenetics Drug Database with emphasis on three large classes of epigenetics-targeting drugs. These are the inhibitors of the DNA methyltransferases (DNMTi), histone deacetylases (HDACi), and histone methyltransferases (HMTi). Together, the three [...]

August 19th, 2016|Categories: News|Tags: , |

Update on the Cancer Epigenetics Clinical Trials Database

The Cancer Epigenetics Society has continued expanding its cancer epigenetic drug clinical trial repository which now covers 500+ clinical trials. These include most if not all reported completed, ongoing, and recruiting cancer clinical trials on DNA methyltransferases (DNMTi), histone deacetylases (HDACi), histone methyltransferases (HMTi), and histone demethylases (KDMi). All databases [...]

August 17th, 2016|Categories: News|Tags: , , , |

Empowering Cancer patients

As a member of the US National Coalition for Cancer Survivorship (NCCS), the Cancer Epigenetics Society asks our members in the States with interest in cancer treatment and survival to help support cancer advocacy in the US. One such initiative is currently undergoing under the umbrella of NCCS to provide [...]

Patient’s resources at CES go local, II

We have continued to expand our country-specific resources to better cater to the needs of local patients. We now provide resources for Austria, Bulgaria, Canada, Cyprus, Ecuador, France, Greece, Nicaragua, Peru, Portugal, Russia, Slovakia, Turkey, the UK, and the US at the Advocacy & Support Group section. More resources for [...]

June 21st, 2016|Categories: News|

The cancer epigenetics of imprinting

Aberrations in the epigenetic phenomenon known as imprinting is a highly frequent early event in tumorigenesis (initiation of cancer) of a large number of tumors including acute myeloid leukemia (AML), Barrett's esophagus, breast cancer, chronic myeloid leukemia (CML), colorectal cancer, esophageal cancer, Ewing's sarcoma, glioma, laryngeal squamous cell carcinoma, hepatoblastoma, [...]

After cancer prevention, aspirin steps up to the plate of cancer treatment?!

We recently reported that frequent low-dose intake of aspirin reduces the risk of developing colorectal and bile duct cancers (read it here). Now a new study from Norway shows that taking aspirin after cancer diagnosis improves survival of people diagnosed with colorectal cancer. In a collaboration between the Cancer Registry [...]

Walking or running away from cancer!

Regular exercise is known to improve cardiovascular function and to reduce the risk or lessen the impact of stress, depression, high blood pressure, stroke, arthritis, osteoporosis, back pain, as well as obesity and certain forms of diabetes. An international collaborative research from the US, Sweden, Norway, Finland, France, and the [...]

May 23rd, 2016|Categories: News|

Radon: radioactivity at home, the silent killer

Recent research from scientists in the US, Canada, and Europe show that residential radon can increase the risk of hematological cancers, particularly of follicular lymphoma and diffuse large B-cell lymphoma. The study analyzed data from 140,652 people in 20 US states and over nearly two decades that were grouped into [...]

May 20th, 2016|Categories: News|Tags: , , , , , , |

Find us on YouTube!

We proudly announce that CES has now its own YouTube channel! We have released our first video which gives a quick overview of the history of DNA chemical changes that accompany many different cellular processes, including those involved in cancer. These changes, the most common of which being DNA methylation, [...]

May 18th, 2016|Categories: News|Tags: , , , , , |

Air pollution goes beyond lung cancer!

Previous research had unsurprisingly linked high levels of fine particulate matter in breathing air (also known as PM2.5) to lung cancer. A new study links PM2.5 in breathing air to increased risk of several cancers including liver, pancreatic, and breast cancer. For example, women had an 80% increase risk of [...]

Of wells, pesticides, epigenetics, and bladder cancer

Exposure to high levels of arsenic was already known to increase the risk of bladder cancer. A new study from the National Cancer Institute (NIH/NCI, Bethesda, USA) of well drinking water in Maine, Vermont, and New Hampshire, found that low doses of arsenic in drinking water, presumably from contaminating pesticides, [...]

May 16th, 2016|Categories: News|Tags: , , , |

Patient’s resources at CES go local

After putting together resources for cancer advocacy and support groups that operate internationally, we now also provide country-specific resources that may better cater to the needs of local patients. As of today, Austria, Bulgaria, Canada, the UK, and the US figure now on our cancer Advocacy & Support group section. [...]

Meeting Austria’s President & First lady Fischer at Vienna’s Hofburg imperial palace

A high level meeting took place yesterday at the impressive Zeremoniensaal (room of ceremonies) at the imperial architectural masterpiece of the Hofburg palace in Vienna, Austria. Several Austrian and foreign dignitaries were present, with Dr. Heinz Fischer, President of Austria, as the guest of honor. The discussions were both informal [...]

One aspirin a day keeps the doctor at bay?

While it is now well established that low-dose, daily or frequent use of aspirin can considerably reduce the risk of cardiovascular disease and colorectal cancers, new findings from the Mayo Clinic at Rochester (MN, USA) show that aspirin can also reduce the risk of cholangiocarcinoma or bile duct cancers. [...]

May 10th, 2016|Categories: News|Tags: , , |

Cooling the scalp to preserve hair during chemo approved in the US:

A method that has been used for some 40 years in Europe to reduce hair loss during chemotherapy, which consists of cooling the scalp with a cold cap, has finally been approved by the United States Food and Drug Administration (FDA) for use by cancer patients in the US. [...]

May 9th, 2016|Categories: News|Tags: , , |